Surg Endosc. 2000 Oct;14(10):896-901.
We compare the use of the HandPort(TM)device in hand-assisted laparoscopic surgery (HALS) to standard laparoscopic surgery (SLS) in the treatment of colorectal disease.
A prospective, randomized, multicenter study was conducted with the participation of 10 advanced laparoscopic surgeons. Forty patients with indications for elective resection of benign colorectal disease or incurable malignant disease were randomized to one of the two treatment arms (22 HALS, 18 SLS). Main outcome measures included operative time, blood loss, HandPort(TM) performance, postoperative pain, time to oral intake, return of bowel function, length of stay, morbidity, and functional recovery.
The patients in each group were similar with regard to age, sex, weight, diagnosis, coexisting medical disease, and preoperative functional status. Operative time was comparable for hand-assisted laparoscopy (152 +/- 66 min) and standard laparoscopy (141 +/- 54 min) (p = 0.58). Incision length for specimen extraction/bowel anastomosis was similar (HALS 7.4 cm vs SLS 7.0 cm). Three of 22 HALS cases (14%) were converted, as compared with four of 18 (22%) in the laparoscopy group (p = 0.68). Return of bowel function occurred by the 3rd postoperative day for the majority of patients in both groups (HALS 77%, SLS 78%). There was no difference in length of stay (HALS 7.0 days [range, 2-12] vs SLS 6.0 days [range, 2-10], p = 0.25). Severity of postoperative pain and rate of functional recovery were equivalent. One major complication occurred in each group. There were three wound infections in the laparoscopy group. No patient required reoperation, and there were no deaths.
Hand-assisted laparoscopic surgery is safe and effective for benign and noncurative colorectal resection. As compared to standard laparoscopic surgery, hand-assisted laparoscopy retains the benefits of minimally invasive surgery and may allow the surgeon to perform complex operations more easily.
我们比较了在结直肠疾病治疗中,手辅助腹腔镜手术(HALS)中使用HandPort™设备与标准腹腔镜手术(SLS)的情况。
一项前瞻性、随机、多中心研究由10名高级腹腔镜外科医生参与进行。40例有择期切除良性结直肠疾病或不可治愈恶性疾病指征的患者被随机分为两个治疗组之一(22例接受HALS,18例接受SLS)。主要观察指标包括手术时间、失血量、HandPort™性能、术后疼痛、开始经口进食时间、肠功能恢复时间、住院时间、发病率和功能恢复情况。
每组患者在年龄、性别、体重、诊断、并存疾病及术前功能状态方面相似。手辅助腹腔镜手术(152±66分钟)与标准腹腔镜手术(141±54分钟)的手术时间相当(p = 0.58)。标本取出/肠吻合的切口长度相似(HALS为7.4厘米,SLS为7.0厘米)。22例HALS病例中有3例(14%)中转开腹,而腹腔镜组18例中有4例(22%)中转开腹(p = 0.68)。两组大多数患者术后第3天肠功能恢复(HALS为77%,SLS为78%)。住院时间无差异(HALS为7.0天[范围2 - 12天],SLS为6.0天[范围2 - 10天],p = 0.25)。术后疼痛严重程度和功能恢复率相当。每组各发生1例严重并发症。腹腔镜组有3例伤口感染。无患者需要再次手术,且无死亡病例。
手辅助腹腔镜手术对于良性和不可治愈性结直肠切除术是安全有效的。与标准腹腔镜手术相比,手辅助腹腔镜手术保留了微创手术的优点,并且可能使外科医生更易于进行复杂手术。